﻿<?xml version="1.0" encoding="utf-8"?>
<rdf:Description rdf:about="https://catalogues.royalsociety.org:443/CalmView/record/catalog/HF/1/19/4/59/44" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dc="http://purl.org/dc/elements/1.1/">
  <dc:title>Letter from Howard Walter Florey to James C Cain, Technical Divsion, National Research Development Corporation, Tilney Street, London</dc:title>
  <dc:description>In long run, should be useful for MRC Antibiotics Clinical Trials Committee to have 500 gm of Cephalosporin C - thought it would be better for them to wait until they have results of Oxforc experiments on the promised 100 gms - heard from Glaxo about difficulties of supply of carbon for Cephalosporin C - comments on this.</dc:description>
  <dc:date>16 March 1956</dc:date>
</rdf:Description>